Protocol for the Administration of Inactivated Influenza Vaccine to. Adults by Registered Nurses via Patient Specific Direction
|
|
- Candice Lang
- 5 years ago
- Views:
Transcription
1 This document has been reviewed in line with the Policy Alignment Process for Liverpool Community Health NHS Trust Services. It is a valid Mersey Care document, however due to organisational change this FRONT COVER has been added so the reader is aware of any changes to their role or to terminology which has now been superseded. When reading this document please take account of the changes highlighted in Part B and C of this form. Part A Information about this Document Protocol for the Administration of Inactivated Influenza Vaccine to Policy Name Adults by Registered Nurses via Patient Specific Direction Policy Type Board Approved (Trust-wide) Trust-wide Divisional / Team / Locality Action No Change Minor Change Major Change New Policy No Longer Needed Approval As Mersey Care s Executive Director / Lead for this document, I confirm that this document: a) complies with the latest statutory / regulatory requirements, b) complies with the latest national guidance, c) has been updated to reflect the requirements of clinicians and officers, and d) has been updated to reflect any local contractual requirements Signature: Date: Part B Changes in Terminology (used with Minor Change, Major Changes & New Policy only) Terminology used in this Document New terminology when reading this Document Vaccine Health Care Assistant Patient Specific Direction Specify Inactivated Influenza Vaccine Registered Nurse Fully defined Part C Additional Information Added (to be used with Major Changes only) Section / Paragraph No Outline of the information that has been added to this document especially where it may change what staff need to do All Clarification around definitions and roles Part D Rationale (to be used with New Policy & Policy No Longer Required only) Please explain why this new document needs to be adopted or why this document is no longer required To support Mersey Care staff to deliver contracted services within the community within a legal framework with regard to the National Vaccination program for Winter Pressures in a timely manner Part E Oversight Arrangements (to be used with New Policy only) Accountable Director Recommending Committee Approving Committee Next Review Date LCH Policy Alignment Process Form 1
2 SUPPORTING STATEMENTS This document should be read in conjunction with the following statements: SAFEGUARDING IS EVERYBODY S BUSINESS All Mersey Care NHS Foundation Trust employees have a statutory duty to safeguard and promote the welfare of children and adults, including: being alert to the possibility of child / adult abuse and neglect through their observation of abuse, or by professional judgement made as a result of information gathered about the child / adult; knowing how to deal with a disclosure or allegation of child / adult abuse; undertaking training as appropriate for their role and keeping themselves updated; being aware of and following the local policies and procedures they need to follow if they have a child / adult concern; ensuring appropriate advice and support is accessed either from managers, Safeguarding Ambassadors or the trust s safeguarding team; participating in multi-agency working to safeguard the child or adult (if appropriate to your role); ensuring contemporaneous records are kept at all times and record keeping is in strict adherence to Mersey Care NHS Foundation Trust policy and procedures and professional guidelines. Roles, responsibilities and accountabilities, will differ depending on the post you hold within the organisation; ensuring that all staff and their managers discuss and record any safeguarding issues that arise at each supervision session EQUALITY AND HUMAN RIGHTS Mersey Care NHS Foundation Trust recognises that some sections of society experience prejudice and discrimination. The Equality Act 2010 specifically recognises the protected characteristics of age, disability, gender, race, religion or belief, sexual orientation and transgender. The Equality Act also requires regard to socio-economic factors including pregnancy /maternity and marriage/civil partnership. The trust is committed to equality of opportunity and anti-discriminatory practice both in the provision of services and in our role as a major employer. The trust believes that all people have the right to be treated with dignity and respect and is committed to the elimination of unfair and unlawful discriminatory practices. Mersey Care NHS Foundation Trust also is aware of its legal duties under the Human Rights Act Section 6 of the Human Rights Act requires all public authorities to uphold and promote Human Rights in everything they do. It is unlawful for a public authority to perform any act which contravenes the Human Rights Act. Mersey Care NHS Foundation Trust is committed to carrying out its functions and service delivery in line the with a Human Rights based approach and the FREDA principles of Fairness, Respect, Equality Dignity, and Autonomy Page 2 of 18
3 Title Protocol reference number Aim and purpose of protocol Author Protocol for the Administration of Inactivated Influenza Vaccine to Adults by Registered Nurses via Patient Specific Direction 176 To enable suitably trained Registered Nurses working for or on behalf of Liverpool and Sefton Community Divisions to administer Influenza vaccine to adults. Modern Matron (Trust Lead Physical Health/Influenza Lead) - Executive Nursing Department Medicines Management Pharmacist Type New Policy Reviewed Policy Review date NOVEMBER 2019 Person/group accountable for review Type of evidence base used ISSUE DATE Authorised by Clinical Standards Group Clinical Standards Group C: Evidence which includes published and/or unpublished studies and expert opinion (limited scientific evidence) NOVEMBER 2018 Agreement at Clinical Standards Group on 29/11/2018 for approval via Delegated Authority. Equality Analysis Undertaken Yes No x Evidence collated Yes No Page 3 of 18
4 Version Control Form Version Number: Ratified by: V1 Clinical Standards Group Date of Approval: Name of originator/author: Approving Body / Committee: Hillary Smith Medicines Optimisation and Safety Group Clinical Standards Group Date issued: November 2018 Review date: November 2019 Target audience: Name of Lead Director / Managing Director: Registered Nurses working for or on behalf of Mersey Care Community Divisions who have undertaken relevant training, to administer influenza vaccine to adults aged 16 years and over Executive Director of Nursing and Operations Changes / Alterations Made To Previous Version: Specified vaccine and target audience Expanded definitions This protocol has been approved at the Medicines Optimisation and Safety Group and agreed via Delegated Authority at Clinical Standards Group on 29/11/2018 Page 4 of 18
5 Contents Page 1 Purpose of Protocol 6 2 Rationale 6 3 Principles 7 4 Training / Skills Training programme Topics covered Continuing Training Requirements 9 5 Authority to proceed Consent Patient Identification Patient Specific Direction 9 6 Eligibility Criteria & Condition to be Treated Criteria for inclusion Criteria for exclusion & circumstances for further advice/ action Treatment, route of administration and legal status Special circumstances Record keeping and audit Significant Events 14 7 References National Guidance Mersey Care Policies 15 8 Appendices Vaccination & Immunisation Option Checklist Consent Process for Influenza Immunisation 16 Resuscitation Council UK Anaphylactic Reaction Initial Treatment 17 Vaccination Competencies 18 Page 5 of 18
6 1. Purpose of Protocol To enable Registered Nurses employed by Mersey Care and working in the Community Divisions who have undertaken relevant training (section 4), to administer inactivated Influenza vaccine to adults aged 16years and over. A single dose of vaccine would be administered as a duty authorised and delegated by a prescriber, either a GP or Non-Medical Prescriber, under a Patient Specific Direction (PSD). It will ensure that all staff employed by the Trust, provide optimal service delivery to this population group. The advice and guidance contained within this protocol is based upon the latest research-based evidence from the Department of Health, Immunisation Against Infectious Disease, The Green Book. National and local policy documents should be read in conjunction with this protocol. Please see References in section Rationale To ensure that patients receive the highest possible level of care during the administration of vaccines. To ensure that Registered Nurses are appropriately trained to deliver the vaccination program. To ensure that Registered Nurses are supported to undertake tasks when delegated via a Patient Specific Direction (PSD). To ensure that Mersey Care Community Divisions can demonstrate resilience when there is a requirement for increased immuniser capacity and the ability to mobilise staff to support the implementation of public health contingency plans during peaks of seasonal flu activity and for any future Flu pandemics. An essential element to the development of this protocol is to ensure Registered Nurses have access to specific guidance in vaccine administration. This protocol underpins a recognised set of competencies based PHE (2018) National Minimum Standards and Core Curriculum for Immunisation Training of Registered Practitioners.. Page 6 of 18
7 3. Principles Registered Nurses, employed by Mersey Care, who have completed the appropriate training for the administration of inactivated influenza vaccine to adults, can be delegated to deliver the service under a Patient Specific Direction (PSD). Registered Nurses will undertake bespoke training as developed by the Trust. Refer to section 4. A PSD is a written instruction signed by a doctor, dentist or non-medical prescriber (hereafter referred to as the prescriber ) for medicines to be supplied or administered to a named patient or patients after the prescriber has assessed the patient on an individual basis. The prescriber retains responsibility and included in that is being assured that the person to whom the task is delegated is competent to complete the task. It is a form of prescribing but is different to an FP10, which would normally be issued to the patient on an individual patient basis only to be dispensed at a pharmacy. A PSD allows the prescriber to manage a group of patients who have the same need. A PSD needs to be written a verbal instruction is not a valid PSD and needs to be signed by the prescriber. The PSD should specify the following: Name of patient and/ or other individual patient identifiers Name, form and strength of medicine Route of administration Dose Frequency Start and finish dates Signature of prescriber Example: a computer generated list of patient names who have been identified by the prescriber as requiring the vaccination, which has been titled with the name, form, strength and route of the single vaccination. It needs to be signed by the prescriber and the period during which he wants these patients to be targeted e.g. 1 October February 2019 These requirements need to be met before the trained registered nurse can proceed to follow this protocol. Page 7 of 18
8 4. Training & Skills 4.1 Initial Training Completion of Consent to Treatment training Completion of Basic Life Support training Completion of Infection Control training The above training will be completed as a pre-requisite to: Completion of trust training on administration of Influenza vaccine Completion of period of supervised practice and assessment against competencies as per National Minimum Standards and Core Curriculum for Immunisation Training of Registered Practitioners (2018) Training and competencies in the correct procedure of administering medication via intra-muscular injection - see Appendix 3 Training to include maintenance of patient/client privacy and dignity at all times and the demonstration at assessment of awareness of different possible injection sites if client has any physical disability e.g. amputation Basic Life Support recognition and treatment of anaphylaxis Knowledge of the management of anaphylaxis in the community. Refer to the green book The National Resuscitation Guidelines on Anaphylaxis, 2008 (annotated with NICE guidance July 2012) Access to and knowledge of the DH guidance Immunisation against infectious disease Green book 4.2 Topics covered Knowledge, skills and practical application relevant to Vaccination and Immunisation Patient / client communication - demonstrating an awareness of Equality & Diversity and access to publications in other languages Appropriate anatomy, physiology and immunology Correct procedure for the administration of the vaccine via intramuscular injection Vaccine delivery, storage and stock control requirements, maintaining the cold chain. Refer to Mersey Care Policy Cautions and side effects related to the administration of inactivated Influenza vaccination Correct disposal of waste. Documentation and policy including accountability and PSDs. Refer to National Guidance Legal aspects of drug administration including consent for further information. Refer to National Guidance Response and treatment of adverse reactions including anaphylaxis and Basic Life Support Access to and Knowledge of current infection control policies. Page 8 of 18
9 4.3 Continuing training requirements Annual update in Basic Life Support and treatment of anaphylaxis Demonstration of competence in relation to this medication within the Personal Development Plan (PDP) and appraisal process (Performance Development Review) Completion of e-learning/attendance at bespoke annual Vaccination & Immunisation update/ refresher as per Trust requirements Any relevant mandatory training introduced by the Trust The immuniser will in conjunction with this protocol refer to all current related Mersey Care policies as listed in Section 7 5. Authority to proceed 5.1 Consent Consent must be obtained prior to proceeding with vaccination. Refer to SD06 Consent to examination and treatment An adult must consent to their own treatment. The Mental Capacity Act 2005 sets out how treatment decisions should be made for people of 16years of age or older who do not have the capacity to make such decisions 5.2 Patient identification This is required prior to administration of a vaccine. Patient must confirm: Name, date of birth, and home address Registered Nurse must confirm that the patient is eligible to receive the vaccination under the PSD 5.3 Patient Specific Direction A Valid Patient Specific Direction (PSD) must be obtained. Page 9 of 18
10 6. Eligibility Criteria and condition to be treated 6.1 Criteria for Inclusion Clinical condition to be treated Criteria for inclusion Active immunisation for adults against influenza disease Patient has been included in a valid PSD signed by the prescriber Aged 65 years and over by 31st of March in the relevant financial year Pregnant women at any stage of pregnancy All patients resident in long stay residential accommodation Any adult patient (16 years and over) who has a confirmed diagnosis of one of the following diseases: o Chronic heart (excluding uncomplicated controlled hypertension), renal, respiratory disease including asthmatics that requires repeated use of inhaled or systemic steroids or with previous history of hospital admissions due to asthma o Chronic neurological disease o Stroke, transient ischaemic attack o Diabetes mellitus o o o o Chronic liver disease Immunosuppression (due to treatment or disease including asplenia or splenic dysfunction and HIV infection at all stages refer to GP for individual assessment) Morbid obesity (class III obesity) adults with a BMI 40/kg/m² Main carer for elderly or disabled person A more in depth list of clinical risk factors can be found in the influenza section of the updated on line Green Book 6.2 Criteria for Exclusion and circumstances for further advice/action Criteria for exclusion Patients/ clients with any of the following: No valid consent Aged under 16 years Current acute febrile illness - immunisation should be postponed until recovered A confirmed anaphylactic reaction to a previous dose of vaccine containing the same antigens, including neomycin or gentamycin (discuss with clinician/gp). Page 10 of 18
11 Circumstances for further advice/action None of the influenza vaccines should be given to those who have had: a confirmed anaphylactic reaction to a previous dose of the vaccine, or a confirmed anaphylactic reaction to any component of the vaccine, (other than ovalbumin) see circumstances for further advice or action section below) Fit and well (no co-morbidities) adults under the age of 65yrs other than those stated above in inclusion criteria, for example main carer for an elderly relative or disabled person Individuals with an uncontrolled bleeding disorder i.e. haemophilia Patients with capacity declined. Counsel with regards to the risks of influenza infections and the protective effect of the vaccine. Document advice given If no capacity documented refer to prescriber for best interest decisions Severe reaction to any vaccine, or influenza vaccine or any vaccine component, including Neomycin or Gentamycin. Refer to prescriber Individuals who have egg allergy may be at increased risk of reaction to influenza vaccines. In recent years, inactivated influenza vaccines that have a very low ovalbumin content have become available with ovalbumin content less than 0.12 μg/ml (equivalent to 0.06 μg for 0.5 ml dose). Refer all patients who have a confirmed anaphylaxis to the prescriber for assessment for egg Pregnancy and breast feeding are not contraindications to receiving Flu vaccination. Pregnant women are in the clinical at risk criteria for Influenza infection; however pregnant women should be offered the opportunity to discuss their pregnancy with their clinician/gp/ registered nurse in relation to influenza infection and vaccination risks and benefits History of Guillain - Barre syndrome refer to prescriber (please note this is not a contra indication but will require a discussion with the prescriber) Acute febrile illness; rearrange vaccination at a later date Maintain all clients dignity at all times. If client is an amputee utilise available alternate limbs. If no alternative limb is available do not proceed. Seek advice from the Immunisation Lead /GP/ registered practice nurse as applicable Page 11 of 18
12 6.3. Treatment, route, administration and legal status Recommended treatment: Route and legal status Dosage Frequency of administration & maximum dosage Follow-up and advice Side effects & their management Inactivated Influenza vaccine to be administered by intramuscular injection into the deltoid muscle (for individuals with an uncontrolled bleeding disorder refer to GP/ registered nurse for subcutaneous vaccination) Prescription Only Medicine (POM) Adults 0.5mls Single administration via Patient Specific Direction (PSD) Seasonal flu vaccination is usually carried out between October and February of each year and it would be unusual to carry on vaccinating people, including pregnant women, after that date. Registered Nurses should seek advice from the Immunisation Lead or GP who can assess the needs of individual patients, taking into account the level of flu-like illness in the community and the fact that the immune response following flu vaccination takes about two weeks to develop fully Re -immunisation is not normally advised within a 12 month period: The patient/client should be referred to the prescriber for advice if re immunisation in the same year is required Follow any DH guidance during influenza pandemic Re-vaccination in 12 months with appropriate seasonal vaccine Local effects: Redness, swelling, hardness at injection site, pain, bruising. A small painless nodule (induration) may also form at the injection site Systemic side effects: Low grade fever recommended treatment with paracetamol. Pyrexia, headache, tiredness, muscle & joint pain Counsel patient that these reactions are rare and usually disappear within 1-2 days. If they do not, or more serious symptoms develop, then the patient should contact the GP. Extremely rare side effects: Immediate reactions e.g. Urticaria, angio-oedema, bronchospasm and anaphylaxis see protocol for treatment of anaphylaxis for appropriate management Neuralgia, paraesthesia, convulsions and transient thrombocytopenia have been reported rarely Page 12 of 18
13 6.4 Special Considerations Special considerations/ Concurrent medication Adverse reactions As above seek expert advice/ discuss if previous history of Guilllain Barre Syndrome. Influenza vaccination is not a contraindication in pregnancy. Patients may be referred to GP for advice. If available a thiomersal free vaccine should be used. Vaccine shortage may necessitate the need for prioritisation of influenza vaccination within the at risk groups. No drug interactions known. The immune response to influenza vaccination is reduced in those who are immunosuppressed or immunodeficient, including HIV patients. Patients should be individually assessed by the consultant team/gp in relation to the risk versus benefit of immunisation. Immunosuppressant therapy eg oral corticosteroids. Chemotherapy or radiotherapy may result in reduced antibody response. The benefits are such that immunisation should be considered. Refer to Clinician/GP or registered nurse immuniser for advice. Ensure that Anaphylactic shock pack is available If general adverse reaction occurs: Record in patient s notes Inform patient s GP as soon as possible. Local reactions should be referred to a practice nurse or GP Inform line manager and complete DATIX incident form If anaphylactic reaction occurs: Give treatment according to Trust policy on anaphylaxis in the community Record in patient s notes Inform patient s GP as soon as possible All suspected adverse reactions to vaccines occurring in individuals where vaccines are labelled with a black triangle ( ) and serious adverse reaction to vaccines should be documented and reported to the Medicines Healthcare products Regulatory Agency (MHRA) via yellow card system. Page 13 of 18
14 6.5 Record Keeping and Audit Items to be recorded in patient s notes Audit Please refer to the Trust Record Management Policy (IT04) and Health Records and Divisional Guidance (IT06) Name of drug, dose, route and site of administration Date of administration Legible batch number/s and expiry date (from outer vaccine box packaging) Printed name and legible signature of person administrating drug (written or electronic) and designation Contraindications checked Action taken if patient refuses vaccine Reactions to vaccination and action taken (see completion of yellow card in adverse reactions section). Registered Nurses will be expected to participate in audit/evaluation in relation to patient outcomes. The Trust will monitor adherence of Mersey Care Community Divisions staff to this Protocol during attendance at training that will include: Annual review with LCH Clinical Audit. Annual Update Q & A. Maintenance of database with record of training. Annual Review of Protocol. 6.6 Significant Events Significant Events (i.e. vaccine error, interruption of cold chain, and Near misses) Any significant event which occurs during or as a result of administration of a vaccine must be reported to the Clinical Lead. All Registered Nurses following this protocol will be expected to: Participate in audit in relation to patient outcomes and the development of this role according to local governance arrangements Comply with the requirements of all relevant Trust policies applicable to their area of operation and local governance arrangements Report and record incidents to the Clinical Lead. Report and record incident via the Trust DATIX reporting system Report and record all potential near misses or adverse incidents in line with Trust Risk Management policy following the protocol for vaccine error or interruption of the cold chain Page 14 of 18
15 7. References 7.1 National Guidance Green Book Royal College of Nursing ( 2015 ) Supporting the delivery of immunisation education.london: RCN Health Protection Agency (2005 )National Minimum standards and core curriculum of immunisation training of health care support workers. London: Public Health England (previous HPA) Available at Roach,M.S. (1984 )Caring: The Human Mode of Being, Implications for Nursing.Ottowa: The Canadian Hospital Association Press NMC Guidelines for Records and Record keeping 7.2 Mersey Care Policies IC01 Infection Control & Prevention SA03 Reporting, Management & Review of Adverse Incidents SA22 Waste Management SD06 Consent to Examination or Treatment SSCSD009 Resuscitation incorporating Anaphylaxis & Deteriorating Patient MM21 Storage, Ordering, Distribution & Administration of Vaccines (Cold Chain) Policy 9 Vaccination & Immunisation Page 15 of 18
16 8. Appendices Appendix 1 Page 16 of 18
17 Appendix 2 Page 17 of 18
18 Appendix 3
Administration of Inactivated Influenza Vaccine
Policy Number LCH-109 This document has been reviewed in line with the Policy Alignment Process for Liverpool Community Health NHS Trust Services. It is a valid Mersey Care document, however due to organisational
More informationTrust-wide. Minor Change. Major Change
Policy Number 110 This document has been reviewed in line with the Policy Alignment Process for Liverpool Community Health NHS Trust Services. It is a valid Mersey Care document, however due to organisational
More informationDocument Details Patient Group Direction Hepatitis A vaccine (Havrix Monodose ) Trust Ref No Local Ref (optional) Main points the
Document Details Title Patient Group Direction Hepatitis A vaccine (Havrix Monodose ) Trust Ref No 1506-41174 Local Ref (optional) Main points the Active immunisation against infection caused by Hepatitis
More informationEnhanced Service Specification. Childhood seasonal influenza vaccination programme 2018/19
Enhanced Service Specification Childhood seasonal influenza vaccination programme 2018/19 Contents Childhood seasonal influenza vaccination programme... 1 Contents... 4 1 Introduction... 5 2 Background...
More informationEnhanced Service Specification. Childhood seasonal influenza vaccination programme 2017/18
Enhanced Service Specification Childhood seasonal influenza vaccination programme 2017/18 2 Enhanced Service Specification Childhood seasonal influenza vaccination programme Version number: 1 First published:
More informationSAMPLE. PGD reviewed by: Dr Tim Patterson, Chris Faldon, John Maloney, Adrian Mackenzie
Patient Group Direction for the Supply or Administration of combined Diphtheria, Tetanus, acellular Pertussis, inactivated Polio vaccine and Haemophilus type b conjugate Vaccine (Infanrix-IPV-HIB) to children
More informationInfluenza Vaccinations: Procedure for the Ordering and Administration at Hospitals and Hostels within SHFT
SH CP 117 Influenza Vaccinations: Procedure for the Ordering and Administration at Hospitals and Hostels within SHFT Summary: Ordering and Administration of Influenza Vaccinations at Hospitals and Hostels
More informationPatient Group Direction For the supply and administration of
Patient Group Direction For the supply and administration of Adsorbed low dose DIPHTHERIA/TETANUS/acellular PERTUSSIS/ inactivated POLIO REPEVAX Vaccine (dtap/ipv) Or Adsorbed DIPHTHERIA/TETANUS/acellular
More informationPrescription only medicines (POMs)
Prescription only medicines (POMs) 2017 Learning objectives Explain the legal framework with which registered health care professionals can administer prescription only medicines Define the role and limitations
More informationPatient Group Direction For The Administration Of H1N1 (Swine Flu) vaccine
n Patient Group Direction For The Administration Of H1N1 (Swine Flu) vaccine October 2009 PGD version template-2009.1 Page 1 of 8 Rationale Patient Group Direction For The Administration Of H1N1 (Swine
More informationPatient Group Direction For the supply and administration of
Patient Group Direction For the supply and administration of HAEMOPHILUS INFLUENZAE TYPE B AND MENINGOCOCCAL C CONJUGATE VACCINE (HIB-MenC) MENITORIX Vaccine By Registered Nurse/Midwife/Health Visitor
More informationPatient Group Direction For the supply and administration of
Patient Group Direction For the supply and administration of COMBINED HEPATITIS A AND HEPATITIS B VACCINE TWINRIX PAEDIATRIC For Children aged 1 year to under 16 years TWINRIX ADULT For Adults and Adolescents
More informationDocument Details. Patient Group Direction
Document Details Title Patient Group Direction (PGD) Hepatitis B Vaccine (Engerix ) Trust Ref No 1505-41182 Local Ref (optional) Main points the Immunisation against Hepatitis B document covers Who is
More informationDocument Details. Ibuprofen 200mg tablets and Ibuprofen oral liquid 100mg in 5ml
Title Document Details Patient Group Direction (PGD) Ibuprofen 200mg tablets and Ibuprofen oral liquid 100mg in 5ml Trust Ref No 1445-36348 Local Ref (optional) Main points the document The treatment of
More informationCommunity Psychiatric Nurse. Consultant Psychiatrist, Substance Misuse Services
PATIENT GROUP DIRECTION (PGD) FOR THE ADMINISTRATION OF HEPATITIS A VACCINE (HAVRIX MONODOSE VACCINE) BY REGISTERED NURSES WORKING IN THE COMMUNITY SUBSTANCE MISUSE TEAMS Version Number : 2 Patient Group
More informationThis document expires on Patient Group Direction No. VI 11
Patient Group Direction (PGD) for The Administration of Combined Inactivated Hepatitis A & Hepatitis B Vaccine (Twinrix adult, Twinrix paediatric) to Adults and Children over one year by Registered Nurses
More informationThis document expires on Patient Group Direction Number VI 19
Patient Group Direction (PGD) for The Administration of Pneumococcal Polysaccharide Vaccine (PPV, Pneumovax II ) to adults over 65 years and at risk groups aged 2 years and over, by Registered Nurses employed
More informationDeveloped By Name Signature Date
Patient Group Direction 2155 version 2.0 Administration / Supply of Inhaled Salbutamol in Asthma by Registered Practitioners employed by Torbay and South Devon NHS Foundation Trust Date of Introduction:
More informationSAMPLE. PGD Reviewed by: Chris Faldon, John Maloney, Tim Patterson, Adrian MacKenzie, Claire Stein
Patient Group Direction for the supply or administration of haemophilus influenzae type B and meningococcal conjugate vaccine to children requiring immunisation as part of the national childhood vaccination
More informationThis document expires on Patient Group Direction No. VI 5
Patient Group Direction (PGD) for The Administration of Combined Adsorbed Diphtheria, Tetanus, Pertussis, (Acellular Component) and Inactivated Poliomyelitis Vaccine (Infanrix-IPV ) to children aged between
More informationManagement of AIDS/HIV Infected Healthcare Workers Policy
Management of AIDS/HIV Infected Healthcare Workers Policy DOCUMENT CONTROL: Version: 4 Ratified by: Corporate Policy Panel Date ratified: 20 July 2017 Name of originator/author: HR Manager Name of responsible
More informationGG&C PGD ref no: 2018/1603 YOU MUST BE AUTHORISED BY NAME, UNDER THE CURRENT VERSION OF THIS PGD BEFORE YOU ATTEMPT TO WORK ACCORDING TO IT
GG&C PGD ref no: 2018/1603 YOU MUST BE AUTHORISED BY NAME, UNDER THE CURRENT VERSION OF THIS PGD BEFORE YOU ATTEMPT TO WORK ACCORDING TO IT Clinical Condition Indication: Inclusion criteria: Active immunisation
More informationAdministration of Hepatitis A and B Vaccine
PRACTICE: Ref No: PGD/ONEL/2011/006 Valid from December 2011 Valid to December 2013 Supersedes PGD: Any previous PGD used to administer Twinrix Adult and Paediatric vaccine Professional groups covered
More informationDocument Details. Patient Group Direction
Document Details Title Patient Group Direction (PGD) Salbutamol Aerosol Inhaler and salbutamol Nebulised Solution Trust Ref No 1569-34313 Local Ref (optional) Main points the document Treatment of acute
More informationCLINICAL CONTENT OF PATIENT GROUP DIRECTION FOR PNEUMOCOCCAL CONJUGATE VACCINE (Prevenar 13 )
Patient Group Direction for Pneumococcal Conjugate Vaccine (Prevenar 13 ) Version: PNEUMOCOCCAL CONJUGATE 2014.1 Start 1 st February 2014 Expiry 31 st January 2017 THIS PATIENT GROUP DIRECTION HAS BEEN
More informationTHIS PATIENT GROUP DIRECTION HAS BEEN AGREED BY THE FOLLOWING ORGANISATIONS:
Patient Group Direction for Pneumococcal polysaccharide vaccine VERSION: PNEUMOCOCCAL POLY-2013.1 (Pneumovax II ) Start 1 st May 2013 Expiry 30 th April 2015 THIS PATIENT GROUP DIRECTION HAS BEEN AGREED
More informationCase scenarios: Patient Group Directions
Putting NICE guidance into practice Case scenarios: Patient Group Directions Implementing the NICE guidance on Patient Group Directions (MPG2) Published: March 2014 [updated March 2017] These case scenarios
More informationThis document expires on Patient Group Direction No. VI 7
Patient Group Direction (PGD) for The Administration of Combined low-dose Diphtheria, Tetanus, and Inactivated Polio Vaccine (Revaxis ) to individuals aged over 10 years, by Registered Nurses employed
More informationPATIENT GROUP DIRECTION. Oral (live attenuated) Typhoid Vaccine (Ty21a) (Vivotif )
PATIENT GROUP DIRECTION Administration of: Oral (live attenuated) Typhoid Vaccine (Ty21a) (Vivotif ) By: Practice Nurses In: General Practice It is the responsibility of the professional working under
More informationPatient Group Directions (PGDs)
Patient Group Directions (PGDs) Document level: Trustwide (TW) Code: MP2 Issue number: 4 Lead executive Authors details Type of document Target audience Document purpose Medical Director Senior Clinical
More informationPatient Group Direction
This Patient Group Direction (PGD) must only be used by registered health professionals who have been named and authorised by their organisation to practice under it. The most recent and in date final
More informationGG&C PGD ref no: 2016/1408 YOU MUST BE AUTHORISED BY NAME, UNDER THE CURRENT VERSION OF THIS PGD BEFORE YOU ATTEMPT TO WORK ACCORDING TO IT
GG&C PGD ref no: 2016/1408 YOU MUST BE AUTHORISED BY NAME, UNDER THE CURRENT VERSION OF THIS PGD BEFORE YOU ATTEMPT TO WORK ACCORDING TO IT Clinical Condition Indication: Active immunisation against disease
More informationGG&C PGD ref no: 2016/1338 YOU MUST BE AUTHORISED BY NAME, UNDER THE CURRENT VERSION OF THIS PGD BEFORE YOU ATTEMPT TO WORK ACCORDING TO IT
GG&C PGD ref no: 2016/1338 YOU MUST BE AUTHORISED BY NAME, UNDER THE CURRENT VERSION OF THIS PGD BEFORE YOU ATTEMPT TO WORK ACCORDING TO IT Clinical Condition Indication: For active immunisation of individuals
More informationEnhanced service specification Childhood seasonal influenza vaccination programme NHS England gateway reference: 01641
Enhanced service specification Childhood seasonal influenza vaccination programme NHS England gateway reference: 01641 Introduction 1. All GMS practices are expected to provide essential and those additional
More informationSouth Staffordshire and Shropshire Healthcare NHS Foundation Trust
South Staffordshire and Shropshire Healthcare NHS Foundation Trust Document Version Control Document Type and Title: Authorised Document Folder: Immunisation Policy YELLOW - Clinical New or Replacing:
More informationPATIENT GROUP DIRECTION PROCEDURE
PATIENT GROUP DIRECTION PROCEDURE Date approved 2 October 2015 Version 3 Approved by Yvette Oade, Chief Medical Officer Procedure Lead Clinical Governance Lead - Medicines Management Procedure Author Karen
More informationDeveloped By Name Signature Date
Patient Group Direction 2156 version 2.0 Administration of Ipratropium 250mcg/ml Nebuliser Solution in Acute Asthma by Registered Practitioners employed by Torbay and South Devon NHS Foundation Date of
More informationpatient group direction
REVAXIS v01 1/12 REVAXIS (DIPHTHERIA, TETANUS AND POLIOMYELITIS (INACTIVATED) VACCINE (ADSORBED, REDUCED ANTIGEN(S) CONTENT)) PGD Details Version 1.0 Legal category Staff grades Approved by POM Paramedic
More informationby registered nurses employed by NHS Hertfordshire or Hertfordshire GP Practices and signatories to the PGD
Notice to all staff: NHS Hertfordshire Patient Group Directions (PGDs) may only be used by members of the healthcare professions named on the title page and only if each professional has individually been
More informationModel the social work role, set expectations for others and contribute to the public face of the organisation.
AMHP Competency PCF capability mapping: Experienced level social worker. 1. Professionalism: Identify and behave as a professional social worker, committed to professional development: Social workers are
More informationPatient Group Directions Policy
Patient Group Directions Policy Category: Summary: Equality Analysis undertaken: Valid From: Date of Next Review: Approval Date/ Via: Distribution: Related Documents: Author(s): Further Information: This
More informationClinical Condition Indication:
Patient Group Direction ( for Health Care GG&C PGD ref no: 2018/1611 YOU MUST BE AUTHORISED BY NAME, UNDER THE CURRENT VERSION OF THIS PGD BEFORE YOU ATTEMPT TO WORK ACCORDING TO IT Clinical Condition
More informationPROCEDURE REF NO SABP/EXECUTIVE BOARD/0017
PROCEDURE REF NO SABP/EXECUTIVE BOARD/0017 NAME OF PROCEDURE: Medicines Procedure: Patient Group Directions for the Administration of Hepatitis B Vaccine for SABP Drug and Alcohol Teams. PURPOSE OF PROCEDURE:
More informationPatient Group Direction
Patient Group Direction For the supply and administration of PNEUMOCOCCAL POLYSACCHARIDE VACCINE (23 VALENT) PNEUMOVAX II Vaccine By Registered Nurse/Midwife/Health Visitor To Adults and children over
More informationCONJUGATE MENINGOCOCCAL (ACWY) VACCINE
Cumbria & Lancashire Vaccine PGD Group ADVISORY INFORMATION FOR USE WITH PATIENT SPECIFIC DIRECTION OR INDIVIDUAL PRESCRIPTION SIGNED BY GP OR NON-MEDICAL PRESCRIBER. CONJUGATE MENINGOCOCCAL (ACWY) VACCINE
More informationSALBUTAMOL INHALER PATIENT GROUP DIRECTION CHILD HEALTH 1. Aim/Purpose of this Guideline
SALBUTAMOL INHALER PATIENT GROUP DIRECTION CHILD HEALTH 1. Aim/Purpose of this Guideline 1.1. This Patient Group Direction (PGD) applies to all nursing and clinical staff in the Child Health Department
More informationPRIMARY CARE CO-COMMISSIONING COMMITTEE. 9 June 2015
Agenda Item No. 9 Part 1 X Part 2 PRIMARY CARE CO-COMMISSIONING COMMITTEE 9 June 2015 Title of Report National Flu Plan Winter 2015/16 Requirement Summary and Trafford CCG Option Appraisal Purpose of the
More informationTrust Policy 218 Ionising Radiation Safety Policy
Trust Policy 218 Ionising Radiation Safety Policy Purpose Date Version August 2016 7 To ensure that Plymouth Hospitals NHS Trust complies with all relevant legislation with regard to the use of ionising
More informationTRUST WIDE DOCUMENT DOCUMENT NUMBER: ELHT Version 1
i TRUST WIDE DOCUMENT DOCUMENT TITLE: SEASONAL INFLUENZA PLAN DOCUMENT NUMBER: ELHT Version 1 DOCUMENT PURPOSE: Seasonal Influenza (Flu) Plan sets out a coordinated and evidence-based approach to planning
More informationSpecialised Services Commissioning Policy. CP29: Bariatric Surgery
Specialised Services Commissioning Policy CP29: Bariatric Surgery Document Author: Specialist Planner, Cardiothoracic Executive Lead: Director of Planning Approved by: Management Group Issue Date: 12 June
More informationPatient Group Direction Hepatitis A vaccine Version: Hepatitis A 2015 Start Date: 1 st July 2015 Expiry Date:30 th June 2018
Patient Group Direction Hepatitis A vaccine Version: Hepatitis A 2015 Start 1 st July 2015 Expiry 30 th June 2018 THIS PATIENT GROUP DIRECTION HAS BEEN AGREED BY THE FOLLOWING ORGANISATIONS: BLACKPOOL
More informationPGD No Administration of Human Papillomavirus Vaccine (HPV) Types 6, 11, 16 and 18 - Gardasil - September 2012
Notice to all staff: NHS Hertfordshire Patient Group Directions (PGDs) may only be used by members of the healthcare professions named on the title page and only if each professional has individually been
More informationEquality of Opportunity Committee
Equality of Opportunity Committee EOC(3)-12-09 (p8) Inquiry into Discrimination against People Living with HIV by Healthcare Professionals and Providers Written evidence from Abertawe Bro Morgannwg University
More informationflu vaccination DRAFT The WINTER 2018/19 Who should have it and why Includes information for children and pregnant women mmunisation
flu vaccination Who should have it and why The WINTER 2018/19 Includes information for children and pregnant women The flu vaccination 1 Winter 2018/19 Flu mmunisation Helping to protect everyone, every
More informationVersion Number: 02. Patient Group Direction drawn up by: Jayne Bruce - Deputy Director of Nursing Standards and Safety Sussex
PATIENT GROUP DIRECTION (PGD) FOR THE ADMINISTRATION OF INFLUENZA VACCINE BY REGISTERED NURSES (PEER VACCINATORS) TO STAFF WORKING FOR SUSSEX PARTNERSHIP NHS FOUNDATION TRUST Version Number: 02 Patient
More informationAssistant Practitioner and Health Care Assistants Administration of Insulin, via Pen device, by Delegation Training and competency Toolkit
Assistant Practitioner and Health Care Assistants Administration of Insulin, via Pen device, by Delegation Training and competency Toolkit Document Summary The purpose of this policy is to guide and promote
More informationHealth and Social Care Workers and Pandemic Influenza
Health and Social Care Workers and Pandemic Influenza Information for staff who are pregnant or in DH INFORMATION READER BOX Policy HR / Workforce Management Planning / Clinical Document Purpose Gateway
More informationClinical Condition Indication:
GG&C PGD ref no: 2012/943 YOU MUST BE AUTHORISED BY NAME, UNDER THE CURRENT VERSION OF THIS PGD BEFORE YOU ATTEMPT TO WORK ACCORDING TO IT Clinical Condition Indication: For active immunisation of individuals
More informationPatient Group Direction for Varicella vaccine Version: Varicella Start Date: 1 st April 2016 Expiry Date: 31 st March 2019
Patient Group Direction for Varicella vaccine Version: Varicella 2016.1 Start Date: 1 st April 2016 Expiry Date: 31 st March 2019 THIS PATIENT GROUP DIRECTION HAS BEEN AGREED BY THE FOLLOWING ORGANISATIONS:
More informationClinical Condition Indication:
GG&C PGD ref no: 2016/1366 YOU MUST BE AUTHORISED BY NAME, UNDER THE CURRENT VERSION OF THIS PGD BEFORE YOU ATTEMPT TO WORK ACCORDING TO IT Clinical Condition Indication: Active immunisation against disease
More informationTemplate Standard Operating Procedure For: Handling of Midazolam and other controlled drugs in Dental Practices
Name of Dental Practice : Objectives To ensure implementation of the regulations and guidance on safe and secure handling of midazolam and other controlled drugs (CDs) Scope To cover all aspects of obtaining
More informationNO SMOKING POLICY. Organisational
NO SMOKING POLICY Policy Title State previous title where relevant. State if Policy New or Revised Policy Strand Org, HR, Clinical, H&S, Infection Control, Finance For clinical policies only - state index
More informationPatient Group Direction for the Supply of Nitrofurantoin MR 100mg capsules
October 2016 Patient Group Direction for the Supply of Nitrofurantoin MR 100mg capsules This Patient Group Direction (PGD) is a specific written instruction for the supply and/or administration of nitrofurantoin
More informationPatient Group Direction for Varicella vaccine Version: Varicella Start Date: 1 st May 2014 Expiry Date: 30 th April 2017
Patient Group Direction for Varicella vaccine Version: Varicella 2014.1 Start Date: 1 st May 2014 Expiry Date: 30 th April 2017 THIS PATIENT GROUP DIRECTION HAS BEEN AGREED BY THE FOLLOWING ORGANISATIONS:
More informationClinician Responsible for Training and Review: Emergency Department Consultant
Patient Group Direction for the Supply of Salbutamol Inhaler to patients receiving treatment from NHS Borders Emergency Department/Out of Hours/Minor Injury Units This document authorises the supply or
More informationInfluenza Campaign (Wales) Code of Practice (The Flu Code)
Influenza Campaign (Wales) Code of Practice (The Flu Code) May 2016 Public Health Wales Influenza Campaign (Wales) Code of Practice Purpose and Summary of Document: This code of practice sets out the minimum
More informationPatient Group Direction For the supply and administration of
Patient Group Direction For the supply and administration of Adsorbed low dose DIPHTHERIA/TETANUS/acellular PERTUSSIS/ inactivated POLIO REPEVAX Vaccine (dtap/ipv) By Registered Nurse/Midwife/Health Visitor
More informationPatient Group Direction for Combined Hepatitis A & B vaccine Version: Hep A + B Start Date: 1 st January 2014 Expiry Date: 31 st December 2015
Patient Group Direction for Combined Hepatitis A & B vaccine Version: Hep A + B 2014.1 Start 1 st January 2014 Expiry 31 st December 2015 THIS PATIENT GROUP DIRECTION HAS BEEN AGREED BY THE FOLLOWING ORGANISATIONS:
More informationAdministration of Injectable Medication by Healthcare Assistants (Band 3) Standard Operating Procedure
Administration of Injectable Medication by Healthcare Assistants (Band 3) Standard Operating Procedure DOCUMENT CONTROL: Version: 1 Ratified by: Quality Assurance Sub Committee Date ratified: 4 September
More informationNHS public health functions agreement Service specification No.32 Human papillomavirus immunisation programme for men who have sex with men
NHS public health functions agreement 2018-19 Service specification No.32 Human papillomavirus immunisation programme for men who have sex with men (HPV-MSM) 1 NHS public health functions agreement 2018-19
More informationPATIENT GROUP DIRECTION (PGD) FOR THE SUPPLY OR ADMINISTRATION OF LEVONORGESTREL 1500 MICROGRAM TABLET (e.g LEVONELLE 1500 ) PGD
This Patient Group Direction () must only be used by registered pharmacists who have been named and authorized by their organization to practice under it. The most recent and in date final signed version
More informationPolicy and Procedure for the Development, Approval and Implementation of Patient Group Directions in NHS Haringey Clinical Commissioning Group
BEFORE USING THIS POLICY ALWAYS ENSURE YOU ARE USING THE MOST UP TO DATE VERSION Policy and Procedure for the Development, Approval and Implementation of Patient Group Directions in NHS Haringey Clinical
More informationHEPATITIS A + TYPHOID VACCINE
GG&C PGD ref no: 2017/1522 YOU MUST BE AUTHORISED BY NAME, UNDER THE CURRENT VERSION OF THIS PGD BEFORE YOU ATTEMPT TO WORK ACCORDING TO IT Clinical Condition Indication: Indicated for active immunisation
More informationMulti-Agency Safeguarding Training. Prospectus April March 2019
Multi-Agency Safeguarding Training Prospectus April 2018- March 2019 Author: Barbara Morris, Workforce Development Lead - Childrens Barbara.morris@northtyneside.gov.uk Contents Click on the course heading
More informationLocal Enhanced Service Specification. MenACWY vaccination programme for 15 and 16 year olds (school year 11) in Cornwall and the Isles of Scilly
Local Enhanced Service Specification MenACWY vaccination programme for 15 and 16 year olds (school year 11) in Cornwall and the Isles of Scilly 1 st January 2016 to 31 st August 2016 1 Local Enhanced Service
More informationGG&C PGD ref no: 2017/1427 YOU MUST BE AUTHORISED BY NAME, UNDER THE CURRENT VERSION OF THIS PGD BEFORE YOU ATTEMPT TO WORK ACCORDING TO IT
GG&C PGD ref no: 2017/1427 YOU MUST BE AUTHORISED BY NAME, UNDER THE CURRENT VERSION OF THIS PGD BEFORE YOU ATTEMPT TO WORK ACCORDING TO IT Clinical Condition Indication: Active immunisation against rotavirus.
More informationIMOVAX POLIO POLIOMYELITIS VACCINE (INACTIVATED) Suspension for injection in prefilled syringe
IMOVAX POLIO POLIOMYELITIS VACCINE (INACTIVATED) Suspension for injection in prefilled syringe Read all of this leaflet carefully before you are vaccinated or before you have your child vaccinated. Keep
More informationUNSCHEDULED VACCINATION OF CHILDREN AND YOUNG PEOPLE WHO HAVE OUTSTANDING ROUTINE IMMUNISATIONS. Service Specification
UNSCHEDULED VACCINATION OF CHILDREN AND YOUNG PEOPLE WHO HAVE OUTSTANDING ROUTINE IMMUNISATIONS Service Specification National Enhanced Service Specification For The Unscheduled Vaccination Of Children
More informationSmoking cessation interventions and services
National Institute for Health and Care Excellence Guideline version (Final) Smoking cessation interventions and services [E] Evidence reviews for advice NICE guideline NG92 Evidence reviews FINAL These
More informationPatient Group Direction For the supply and administration of
Patient Group Direction For the supply and administration of Vi Capsular Polysaccharide Typhoid Vaccine(Ty2) Brands TYPHERIX Vaccine TYPHIM Vi Vaccine To adults and/or children over 2 years of age Or Oral
More informationPATIENT GROUP DIRECTION (PGD) Supply of potassium iodide 65mg tablets to adults and children exposed to, or at risk of exposure to radioactive iodine
PHE publications gateway number: PATIENT GROUP DIRECTION (PGD) Supply of potassium iodide 65mg tablets to adults and children exposed to, or at risk of exposure to radioactive iodine For the supply of
More informationClinician Responsible for Training and Review: Emergency Department Consultant
Patient Group Direction for the supply and/or administration of Paracetamol Oral Suspension 250mg/5ml (Paracetamol paediatric suspension) to children receiving treatment from NHS Borders services. This
More informationSCIMP Guidance for Seasonal Influenza Vaccination Programme. Version 1.0 October Types of vaccine.. p2. 2. Groups requiring vaccination..
SCIMP Guidance for Seasonal Influenza Vaccination Programme Version 1.0 October 2011 Click on the heading below to go to the relevant place in the document 1. Types of vaccine.. p2 2. Groups requiring
More informationSets out clearly the DoH s expectations of the NHS and the roles and responsibilities of each part of the system over the coming months.
NORTH EAST AMBULANCE SERVICE NHS TRUST UPDATE AND RESILIENCE ACTIONS FOR NHS BOARDS REPORT BY : Director of Ambulance Operations INTRODUCTION As Board members are aware, the World Health Organisation (WHO)
More informationJob Title Name Signature Date. Director of Nursing Angela Wallace Signed Angela Wallace 30/6/2014
PATIENT GROUP DIRECTIONS FOR SUPPLY OF VARENICLINE (CHAMPIX ) BY AUTHORISED COMMUNITY PHARMACISTS WORKING IN FORTH VALLEY Protocol Number 445 Version 1 Date protocol prepared: June 2014 Date protocol due
More informationPatient Group Direction No. VI 17. Kathy Wakefield/Lisa Murray. General Practices & TRFT. Relevant Clinical Lead
T i:1 Patient Group Direction (PGD) for The Administration of Meningococcal Group C Conjugate Vaccine (Meningitec /NeisVac-C /Menjugate Kit ) by Registered Nurses employed or commissioned by NHS Rotherham
More informationNHS PREPAREDNESS FOR A MAJOR INCIDENT
NHS PREPAREDNESS FOR A MAJOR INCIDENT In light of the recent tragic events in Paris, NHS England has asked that the Trust reviews the following, and that assurance is provided in the form of a Statement
More informationPATIENT GROUP DIRECTION SUPPLY of Emergency Hormonal Contraception To females under 25 years Levonelle 1500 (Levonorgestrel 1500 micrograms)
PATIENT GROUP DIRECTION SUPPLY of Emergency Hormonal Contraception To females under 25 years Levonelle 1500 (Levonorgestrel 1500 micrograms) VALID FROM: 1 st July 2016 REVIEWED DATE: 30 th June 2019 This
More informationNICE guidelines. Flu vaccination: increasing uptake in clinical risk groups and health and social care workers
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE NICE guidelines Equality impact assessment Flu vaccination: increasing uptake in clinical risk groups and health and social care workers The impact on
More informationIntravenous Pamidronate in the treatment of Hypercalcaemia in the community IV Therapy Team January 2014 Page 1 of 16
Policy Number LCH-20 This document has been reviewed in line with the Policy Alignment Process for Liverpool Community Health NHS Trust Services. It is a valid Mersey Care document, however due to organisational
More informationNHS Sheffield Community Pharmacy Seasonal Flu Vaccination Programme for hard to reach at risk groups (and catch up campaign for over 65s)
NHS Sheffield Community Pharmacy Seasonal Flu Vaccination Programme for hard to reach at risk groups 2012-13 (and catch up campaign for over 65s) Service Evaluation! Supported by Sheffield!Local!Pharmaceutical!Committee!
More information2010 National Audit of Dementia (Care in General Hospitals) Guy's and St Thomas' NHS Foundation Trust
Royal College of Psychiatrists 2010 National Audit of Dementia (Care in General Hospitals) Organisational checklist results and commentary for: Guy's and St Thomas' NHS Foundation Trust The 2010 national
More informationSAFE HANDLING OF VACCINES
STANDARD OPERATING PROCEDURE SAFE HANDLING OF VACCINES Issue History Issue Version One Purpose of Issue/Description of Change Planned Review Date To ensure vaccines are stored in accordance with manufacturers
More informationThe Newcastle upon Tyne Hospitals NHS Foundation Trust. Pre-filled Patient Controlled Analgesia (PCA) syringes
The Newcastle upon Tyne Hospitals NHS Foundation Trust Pre-filled Patient Controlled Analgesia (PCA) syringes Version.: 2.2 Effective From: 1 June 2016 Expiry Date: 1 June 2019 Date Ratified: 20 April
More informationSpecialised Services Policy:
Specialised Services Policy: CP35 Cochlear Implants Document Author: Specialised Planner for Women & Children s Services Executive Lead: Director of Planning Approved by: Executive Board Issue Date: 05
More informationMeeting of Bristol Clinical Commissioning Group Governing Body
Meeting of Bristol Clinical Commissioning Group Governing Body To be held on Tuesday 24 February 2015 commencing at 13:30 at the Vassall Centre, Gill Avenue, Bristol, BS16 2QQ Title: OFSTED Report Agenda
More informationTitle: Influenza Immunization Number: TCFHT-MD03 Activation Date: Review Date:
MEDICAL DIRECTIVE Influenza Immunization Number: TCFHT-MD03 Activation Date: 10-06-2014 Review Date: 15-09-2014 Sponsoring/Contact Person(s) (name, position, contact particulars): Shawn Goodman, RPh, PharmD
More informationService Level Agreement for the Provision of Level 1 Substance Misuse Services from a Community Pharmacy under contract to NHS Grampian
Service Level Agreement for the Provision of Level 1 Substance Misuse Services from a Community Pharmacy under contract to NHS Grampian 1. Introduction The provision of Substance Misuse (SM) services through
More informationSpecialised Services Commissioning Policy: CP34 Circumcision for children
Specialised Services Commissioning Policy: CP34 Circumcision for children March 2019 Version 3.0 Document information Document purpose Document name Author Policy Circumcision for Children Welsh Health
More information